Document is current

Any future updates will be listed below

SELECT shows cardiovascular risk reduction with weight-loss drug semaglutide in people without diabetes

Crossref DOI link: https://doi.org/10.1038/s41569-023-00970-3

Published Online: 2023-11-30

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark